CompletedNot Applicable

The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination

Turkey (Türkiye)60 participantsStarted 2024-08-01

Plain-language summary

Objective The aim of this study was to evaluate the effects of ShotBlocker administration during measles-mumps-rubella (MMR) vaccination on infants' pain level and mothers' satisfaction. Method. The study was conducted in a Family Health Center affiliated to the Public Health Directorate of a province in eastern Turkey between August and October 2024 using a randomized controlled experimental design. The study sample consisted of 60 infants who received MMR vaccination (ShotBlocker group: n = 30, control group: n = 30). Infants in the ShotBlocker group received ShotBlocker before vaccine injection, while infants in the control group received only routine vaccine injection. Infant information form, FLACC pain scale and Newcastle Satisfaction with Nursing Care Scale were used for data collection. Ethical principles were followed throughout the study.

Who can participate

Age range12 Months – 12 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * He's 12 months old, * MMR vaccine will be administered, * growth-development is normal, * no analgesic medication was given during the day, * at least high school graduate * mothers who volunteered to participate in the study Exclusion Criteria: * Neurological disease, * a chronic disease, * allergy (egg allergy) * infants with symptoms of hyperthermia

What they're measuring

Face, Legs, Activity, Crying, Consolability Pain Scala

Timeframe: pre-test post-test (approximately three months)

Trial details

NCT IDNCT06762938

SponsorYuzuncu Yil University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-20

View on ClinicalTrials.gov More Pain trials